Kintor Pharmaceutical Limited (KNTPF)
USD 0.18
(0.0%)
USD 0.18
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 253.92 Million CNY | -11.34% |
| 2022 | 286.38 Million CNY | 79.29% |
| 2021 | 159.73 Million CNY | -27.95% |
| 2020 | 221.7 Million CNY | 245.89% |
| 2019 | 64.09 Million CNY | -7.96% |
| 2018 | 69.64 Million CNY | 54.76% |
| 2017 | 45 Million CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| 2015 | - CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 234.3 Million CNY | -7.73% |
| 2024 Q2 | 234.3 Million CNY | 1.92% |
| 2023 Q2 | 322.56 Million CNY | 1.31% |
| 2023 FY | 253.92 Million CNY | -11.34% |
| 2023 Q1 | 318.39 Million CNY | 11.18% |
| 2023 Q4 | 253.92 Million CNY | 1.82% |
| 2023 Q3 | 249.39 Million CNY | -22.69% |
| 2022 Q2 | 234.53 Million CNY | 2.26% |
| 2022 Q4 | 286.38 Million CNY | 1.57% |
| 2022 Q1 | 229.35 Million CNY | 43.59% |
| 2022 FY | 286.38 Million CNY | 79.29% |
| 2022 Q3 | 281.95 Million CNY | 20.21% |
| 2021 Q1 | 137.7 Million CNY | -37.89% |
| 2021 FY | 159.73 Million CNY | -27.95% |
| 2021 Q4 | 159.73 Million CNY | 1.31% |
| 2021 Q3 | 157.66 Million CNY | 12.86% |
| 2021 Q2 | 139.69 Million CNY | 1.45% |
| 2020 Q3 | 218.99 Million CNY | 3.21% |
| 2020 FY | 221.7 Million CNY | 245.89% |
| 2020 Q1 | 209.13 Million CNY | 226.28% |
| 2020 Q2 | 212.18 Million CNY | 1.46% |
| 2020 Q4 | 221.7 Million CNY | 1.24% |
| 2019 Q4 | 64.09 Million CNY | 5.06% |
| 2019 Q1 | - CNY | 0.0% |
| 2019 FY | 64.09 Million CNY | -7.96% |
| 2019 Q3 | 61.01 Million CNY | 0.0% |
| 2018 FY | 69.64 Million CNY | 54.76% |
| 2017 Q3 | 45 Million CNY | 164.71% |
| 2017 FY | 45 Million CNY | 0.0% |
| 2017 Q1 | 17 Million CNY | 0.0% |
| 2017 Q2 | 17 Million CNY | 0.0% |
| 2017 Q4 | 45 Million CNY | 0.0% |
| 2016 Q4 | - CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |
| 2016 Q1 | - CNY | 0.0% |
| 2016 Q3 | - CNY | 0.0% |
| 2015 FY | - CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Bioxytran, Inc. | 1.92 Million USD | -13090.649% |
| Eiger BioPharmaceuticals, Inc. | 41.2 Million USD | -516.266% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -63087.914% |
| SQZ Biotechnologies Company | 27.47 Million USD | -824.32% |
| Intellipharmaceutics International Inc. | 2.32 Million USD | -10816.806% |
| Evofem Biosciences, Inc. | 43.37 Million USD | -485.433% |
| Santhera Pharmaceuticals Holding AG | 29.76 Million USD | -753.021% |
| Propanc Biopharma, Inc. | 948.27 Thousand USD | -26677.155% |
| Marizyme, Inc. | 18.71 Million USD | -1256.592% |
| Genus plc | 233.1 Million USD | -8.932% |
| Pharming Group N.V. | 171.54 Million USD | -48.019% |
| Therapeutic Solutions International, Inc. | 888.06 Thousand USD | -28492.534% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -18798.707% |
| Nymox Pharmaceutical Corporation | 750 Thousand USD | -33756.0% |
| ContraFect Corporation | 2.88 Million USD | -8713.606% |
| RegeneRx Biopharmaceuticals, Inc. | 1.44 Million USD | -17456.293% |
| IMV Inc. | 28.88 Million USD | -779.106% |
| AXIM Biotechnologies, Inc. | 5.65 Million USD | -4387.525% |
| ONE Bio Corp. | 19.71 Million USD | -1187.952% |
| RVL Pharmaceuticals plc | 57.48 Million USD | -341.684% |
| Mesoblast Limited | 118.7 Million USD | -113.917% |
| MultiCell Technologies, Inc. | 202.58 USD | -125342974.341% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| Emmaus Life Sciences, Inc. | 33.1 Million USD | -667.107% |
| Genscript Biotech Corporation | 417.73 Million USD | 39.216% |
| Neon Bloom, Inc. | 630.07 Thousand USD | -40199.836% |
| Mosaic ImmunoEngineering Inc. | 1.22 Million USD | -20571.448% |
| Nanobac Pharmaceuticals, Incorporated | 4.12 Million USD | -6060.181% |
| Biomind Labs Inc. | 735.54 Thousand USD | -34421.482% |
| Provectus Biopharmaceuticals, Inc. | 3.02 Million USD | -8290.746% |
| Oncotelic Therapeutics, Inc. | 12.99 Million USD | -1853.682% |
| Skye Bioscience, Inc. | 4.61 Million USD | -5401.741% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -70490.198% |
| VioQuest Pharmaceuticals, Inc. | 2.93 Million USD | -8565.064% |
| THC Farmaceuticals, Inc. | 141.51 Thousand USD | -179325.939% |
| PsyBio Therapeutics Corp. | 135.48 Thousand USD | -187312.815% |
| Arch Therapeutics, Inc. | 5.87 Million USD | -4224.921% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Acro Biomedical Co., Ltd. | 25.71 Thousand USD | -987185.664% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 1.49 Million USD | -16887.445% |
| Q BioMed Inc. | 4.1 Million USD | -6078.131% |
| GB Sciences, Inc. | 1.75 Million USD | -14332.956% |
| Alpha Cognition Inc. | 1.22 Million USD | -20706.77% |
| CSL Limited | 12.18 Billion USD | 97.916% |
| Agentix Corp. | 50 Thousand USD | -507740.0% |
| American Oriental Bioengineering, Inc. | 67.64 Million USD | -275.383% |
| Enzolytics Inc. | 996.33 Thousand USD | -25385.327% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Resverlogix Corp. | 6.49 Million USD | -3811.878% |
| Nuo Therapeutics, Inc. | 255.59 Thousand USD | -99245.832% |
| MetaStat, Inc. | - USD | -Infinity% |
| Curative Biotechnology, Inc. | 2.25 Million USD | -11143.453% |
| argenx SE | 20 Million USD | -1169.6% |
| Northwest Biotherapeutics, Inc. | 45.56 Million USD | -457.331% |
| HST Global, Inc. | 98.31 Thousand USD | -258161.374% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | 248.72 Thousand USD | -101990.704% |
| Halberd Corporation | 150 Thousand USD | -169180.0% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | -3490.087% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | 10.22 Thousand USD | -2483225.183% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | -9274.228% |
| GeneThera, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.39 Million USD | -10490.043% |
| AVAX Technologies, Inc. | - USD | -Infinity% |
| WPD Pharmaceuticals Inc. | 229.29 Thousand USD | -110641.372% |
| Cotinga Pharmaceuticals Inc. | 148.65 Thousand USD | -170712.76% |
| Ember Therapeutics, Inc. | 200.61 Thousand USD | -126470.164% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Adynxx, Inc. | - USD | -Infinity% |
| NovAccess Global Inc. | 2.19 Million USD | -11442.448% |
| Helix BioMedix, Inc. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 20.32 Million USD | -1149.115% |
| Kadimastem Ltd | 891.22 Thousand USD | -28391.09% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| BioStem Technologies, Inc. | 4.71 Million USD | -5289.461% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 250.18 Thousand USD | -101394.112% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| LadRx Corporation | 33.6 Thousand USD | -755479.361% |
| Cell Source, Inc. | 9.25 Million USD | -2643.843% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -33478.241% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -33478.241% |
| Affymax, Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | 484.28 Thousand USD | -52332.044% |
| Itoco Inc. | 228.37 Thousand USD | -111084.576% |
| Rasna Therapeutics, Inc. | 210.97 Thousand USD | -120255.492% |
| Pathfinder Cell Therapy, Inc. | 4.98 Million USD | -4995.725% |
| International Stem Cell Corporation | 4.17 Million USD | -5977.549% |
| CytoDyn Inc. | 30.07 Million USD | -744.261% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | 351.84 Thousand USD | -72067.732% |
| Alseres Pharmaceuticals, Inc. | 7.81 Million USD | -3147.075% |
| SYBLEU INC | 477.5 Thousand USD | -53076.963% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 122.5 Thousand USD | -207181.633% |
| Rebus Holdings, Inc. | 310 Thousand USD | -81809.677% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 4.73 Million USD | -5262.299% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -406738.319% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | -11542.9% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 8.31 Million USD | -2953.391% |
| Adhera Therapeutics, Inc. | 8.58 Million USD | -2857.717% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 1.55 Million USD | -16224.232% |
| Innovation Pharmaceuticals Inc. | 268 Thousand USD | -94646.269% |
| Neutra Corp. | 54.15 Thousand USD | -468767.715% |
| Windtree Therapeutics, Inc. | 1.83 Million USD | -13775.41% |
| PureTech Health plc | 25.51 Million USD | -895.296% |
| Coeptis Therapeutics, Inc. | 1.22 Million USD | -20641.268% |
| IXICO plc | 472.02 Thousand USD | -53693.989% |
| IntelGenx Technologies Corp. | 15.5 Million USD | -1538.088% |
| Gelesis Holdings, Inc. | 62.26 Million USD | -307.818% |
| CSL Limited | 12.18 Billion USD | 97.916% |
| Cellectis S.A. | 92.77 Million USD | -173.69% |